Ami Bavishi Joins Rallybio to Lead Investor Relations and Corporate CommunicationsBusiness Wire • 01/18/22
Rallybio Highlights Portfolio Advances and Outlines Expected Upcoming Milestones for 2022Business Wire • 01/06/22
Rallybio Reports Positive Data in Its Clinical Program for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)Business Wire • 12/01/21
Rallybio Corporation to Present at the 4th Annual Evercore ISI HealthCONx ConferenceBusiness Wire • 11/24/21
Rallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business HighlightsBusiness Wire • 11/10/21
Rallybio Corporation Reports Second Quarter 2021 Financial Results and Recent Business HighlightsBusiness Wire • 09/09/21
Monday Afternoon Analyst Upgrades and Downgrades: Chesapeake Energy, Traeger and More24/7 Wall Street • 08/23/21
Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesBusiness Wire • 08/02/21